A reporter cell line for the automated quantification of SARS-CoV-2 infection in living cells
The SARS-CoV-2 pandemic and the urgent need for massive antiviral testing highlighted the lack of a good cell-based assay that allowed for a fast, automated screening of antivirals in high-throughput content with minimal handling requirements in a BSL-3 environment. The present paper describes the c...
Saved in:
Published in | Frontiers in microbiology Vol. 13; p. 1031204 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media
29.09.2022
Frontiers Media S.A |
Subjects | |
Online Access | Get full text |
ISSN | 1664-302X 1664-302X |
DOI | 10.3389/fmicb.2022.1031204 |
Cover
Summary: | The SARS-CoV-2 pandemic and the urgent need for massive antiviral testing highlighted the lack of a good cell-based assay that allowed for a fast, automated screening of antivirals in high-throughput content with minimal handling requirements in a BSL-3 environment. The present paper describes the construction of a green fluorescent substrate that, upon cleavage by the SARS-CoV-2 main protease, re-localizes from the cytoplasm in non-infected cells to the nucleus in infected cells. The construction was stably expressed, together with a red fluorescent nuclear marker, in a highly susceptible clone derived from Vero-81 cells. With this fluorescent reporter cell line, named F1G-red, SARS-CoV-2 infection can be scored automatically in living cells by comparing the patterns of green and red fluorescence signals acquired by automated confocal microscopy in a 384-well plate format. We show the F1G-red system is sensitive to several SARS-CoV-2 variants of concern and that it can be used to assess antiviral activities of compounds in dose–response experiments. This high-throughput system will provide a reliable tool for antiviral screening against SARS-CoV-2. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 PMCID: PMC9558224 Reviewed by: Jun Wang, Rutgers, The State University of New Jersey, United States; Eve-Isabelle Pecheur, INSERM U1052 Centre de Recherche en Cancerologie de Lyon, France This article was submitted to Virology, a section of the journal Frontiers in Microbiology Edited by: Shiu-Wan Chan, The University of Manchester, United Kingdom |
ISSN: | 1664-302X 1664-302X |
DOI: | 10.3389/fmicb.2022.1031204 |